|
Mr. Fallon joined Halozyme in 2006. He was previously President and Chief Executive Officer and a member of the board of directors of Cytovance Biologics a contract manufacturing organization that provides manufacturing and development services to the biotechnology industry. At Cytovance Mr. Fallon oversaw the design construction and validation of a state-of-the-art greenfield cGMP manufacturing facility. From 2001 to 2003 he was Vice President of Technical Operations at Genzyme Corporation having held the same position at Novazyme Pharmaceuticals Inc. prior to its $138 million acquisition by Genzyme in 2001. He joined Novazyme and Genzyme from Transkaryotic Therapies where he was VP of Manufacturing from 1998 to 2001. From 1993 through 1998 he was employed in several management positions for the Ares-Serono Group culminating in the position of Vice President US Manufacturing Operations. In this role he served as general manager overseeing the production and distribution of all of Serono's approved biotechnology products. From 1990 to 1992 he was Director of Manufacturing for Centocor Inc. His prior experience also includes various management and operational roles at Invitron Corporation and Travenol-Genentech Diagnostics. Mr. Fallon earned a B.S. degree in Marine Science and a B.A. degree in Biology from Long Island University and an M.S. degree in Biology from Northeastern University. | 